Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Citalopram	101
Overall Study	STARTED	Placebo (Sugar Pill)	99
Overall Study	STARTED	CGT With Citalopram	99
Overall Study	STARTED	CGT With Placebo	96
Overall Study	Completed Week 12 Assessment	Citalopram	69
Overall Study	Completed Week 12 Assessment	Placebo (Sugar Pill)	69
Overall Study	Completed Week 12 Assessment	CGT With Citalopram	76
Overall Study	Completed Week 12 Assessment	CGT With Placebo	75
Overall Study	COMPLETED	Citalopram	73
Overall Study	COMPLETED	Placebo (Sugar Pill)	61
Overall Study	COMPLETED	CGT With Citalopram	76
Overall Study	COMPLETED	CGT With Placebo	76
Overall Study	NOT COMPLETED	Citalopram	28
Overall Study	NOT COMPLETED	Placebo (Sugar Pill)	38
Overall Study	NOT COMPLETED	CGT With Citalopram	23
Overall Study	NOT COMPLETED	CGT With Placebo	20

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01179568/flow